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Abstract
A high incidence of subnormal serum folic acid levels was observed in 48 patients receiving
anticonvulsants (75 %). In peripheral blood, macrocytosis was detected in 46 % and an increase
of hypersegmented neutrophils was also seen in 24 % of the patients. Correlation existed between
these signs and low serum folate levels. The growth response of Lactobacillus casei and L. le-
ichmannii was not suppressed by the addition of various anticonvulsants to the medium of the
bioassay systems. Administration of 5 mg of folic acid for a month corrected macrocytosis and
an increase of hypersegmented neutrophils significantly. Folic acid supply also decreased mean
diameters of the nuclei of oral epithelial cells significantly. It is concluded that subclinical folic
acid deficiency is common among the patients receiving anticonvulsants. Absorption of 3H.folic
acid from the small intestine of rats was inhibited by large dose of diphenylhydantoin (20 mg) not
by 5 mg. This fact suggests that in patients on diphenylhydantoin, the quantity balance of folic
acid and diphenylhydantoin in the intestine regulates the absorption of folic acid.
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The occasional development of megaloblastic anemia during anticon-
vulsant drug therapy has been well documented (1,2, 3, 4, 5, 6). Response
to folic acid has invariably been complete and the folic acid deficiency
was revealed by special examinations. Though the development of me.
galoblastic anemia is rare, subc1inical folic acid deficiency was observed
in patients receiving anticonvulsants (5, 6, 7, 8, 9, 10). The cause of the
folic acid deficiency in these patients is still unknown. A role of nutritional
factor for the devolopment of the megaloblastic anemia in two patients
was reported in the previous study of the author (4), The present study
reports the results of a survey of forty.eight patients who were being
administered anticonvulsants and an experiment using 3H.folic acid to
study the effect of diphenylhydantoin (DPH) on the absorption of folic
acid from the small intestine of rats.
MTERIAl.S AND METHODS
1. Clinical study
a. Patients studied: Forty-eight patients (Thirty-four males and fourteen
females) taking anticonvulsants in the three psychiatric hospitals in Okayama
Prefecture were investigated. The majority were on combined drug regimen of
DPH, Primidone (Mysoline) and phenobarbital. Folic acid was not supplied for
them. Some of them were supplied with vitamin BIz (BIZ) orally. Duration of the
anticonvulsant therapy ranged from one year to eighteen years (Table 1).
b. Laboratory methods: 0) Peripheral blood counts: one ml of preprandial
venous blood was taken. "Anticlot ET" (Composed of EDTA .2Na and crude
heparin) was used to prevent coagulation. The hematological methods used were
those set by DACIE and LEWIS (1). The mean corpuscular diameter (MCD) was
calculated using Price-]ones curves by measuring five hundred red blood
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TABLE 1 RESULTS OF THE EXAMINATIONS ON PATIENTS RECEIVING ANTICONVULSANTS (I) c..n
t-:)
I Age, \ AnticonVUlsants'l Hb IRBC I I Ht IMCVIMCD IMacyo-I IHyper-! Ret IPlatelet I Iron IFolate IVitamin BI2
No. sex duration (year) (g/dl) (X lO i ) C. I. (%) (cu. fl) (fl) cytes(%) WBC seg. (%) (%0) (X lOi ) (flg/dl) (ng/ml) (pg/ml)
1 125 ~ I /14.21 487 I0.91 /44.0 I 90.3/ I 8.4 I 8,000 I 16 I 4 I 14.6 I 121 I 4.0 I 500D+P I 7.8114.7 ,496 0.95 i 45.0 91 7.8 8.4 7,300 8 6 17.9 149 54.0 300
21 30 ~ 1 1 12 .9 I 395 I I.02 1 4I.0 1 103 .8 / 8 .0 I 13.6 I 4,iOOI 10 I 2 I 13.6 I 108 I I 280D+M+P 5 I 4.013.4 414 I 1.04 41.5 100 8.0 11.0 4,200 3 4 21.5 184 I 52.0 200
3/44 ~ I M+P 5 /15.61 461 /1.06149.0 1 104 I 8.31 24.0 I 6,300 I 13 II~ , 19.8 I 174 I 1.6 I 30015.0 490 0.98 46.0 94 7.8 3.2 6,400 5 18.5 121 SO.O 280
4135 ~ I M+P 15 /12.2/ 358 /1.07/37.5/105 I 8.1 I 12.0 I 4,200/ 26 I 5 I 15.6 I 86 , 2.0 I 33013.0 403 1.02 40.0 98 7.8 4.4 5,000 2 7 15.9 161 56.0 330
51 54 ~ I M+P 7 /13.4' 400 I 1. 07 1 41.0 1 102 .5 1 7.71 3.6 I 6,300 I 5 116 I 9.3 I 98 I 8.6 I 45013.5 412 1.05 39.0 95 7.2 2.8 7,300 4 21.8 liS 33.4 260
61 37 ~ I M+P 3 114.61 437 11.05143.51 99.5/ 7.8/ 6.4 '10,600 I 13 I 4 I 17.5 92 I 1.8 I 700 t:e14.0 I 426 1.05 42.0 98 7.8 4.8 8,900 3 7 17.0 85 47.0 520 >-j
7[20 ~ I 11 j I >II I. 41 326 I I.09/35.0 1 107 A/ 8.21 14.8 I 5,0001 13 I 10.0 1 ISO 2.6 I 480 0M+P 2 c11.8 355 1.06 35.5 100 8.0 8.2 5,100 0 24.9 124 33.0 , 280 C'l:t:
81 28 ~ I I I 14.4 I -M+P 8 /14.4/ 424 1 1.06/43.5/102.61 7.9 j 17.0 I 5, 400 1 15 2 90 I 2.4 I 32013.3 428 1.00 42.5 99 8.0 13.6 5,400 .') 5 23.5 ! 45.0 230
91 44 ~ I D+P 3 II I. 0 I 266 11. 29/34.0 1 127 .8 1 8.51 17 A I 3,300 I 25 I 3 I 13.3 I 86 I 1.0 , 3009.8 I 295 1.06 31.5 107 8.2 15.6 4,800 6 7 27.1 59 43.0 140
10 124 ~ I P 7 I 16.1 I 449 I 1. 26 1 46 .0 1 102 I 7.71 3.6 I 4,800 I 27 I 4 1 10.7 I 141 I 2.0 I 600I 14.1 428 1.05 43.0 100 7.9 8.0 4,800 6 9 21.0 110 38.0 280
11120!f1 D+P 2 /13.2/41910.99/39.5194.31 7.7/ 3.6 I 6,700 I 28 I 5 I 12 ..'i I 98 I 2.5 I 60013.1 421 1.00 37.0 88 7.7 4.0 6,300 I 8 29.0 83 40.0 240
12 I40 t I P 12 111.1 I 3'i2/ 0.99/34.0 /96.6/ 7.8/ 8.8 I 6,700/ 24 I I I 13.4 I 102 I 2.4 I 5SO10.7 353 0.97 31.5 89 7.9 3.2 9,200 6 7 17.7 81 62.0 210
13
1
18 ~ I M+P 4 114.0 I 401 i 1.09/38.51 96 I 7.8/ 6.8 I 3,5001 16 11 ~ I 11. 2 I 145 I 1.8 I 4.'i012.9 420 i 0.98 40.0 I 95 7.8 3.6 4,300 3 20.2 127 53.0 200
14144!f1 D+P 4 Ill.0 I 302 11. 14 1 34 1 112 .6/ 8 . 3 I 26.4 I 4,0001 9 11~ I 15.0 I 108 I 1.1 I 45012.6 374 1.03 38.5 103 8.1 18.1 5,100 6 15.7 160 36.0 380
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TABLE 1 RESULTS OF THE EXAMINATIONS ON PATIENTS RECEIVING ANTICONVULSANTS (2)
N IA I Anticonvulsants, Hb I REC I C I I Ht IMCV IMCD IMacro-! WE I Hyper IPlatelet I Folate IVitamin BI2
o. ge, sex Duration (year) (g/rll) (X lOt) .. (%) (cu. ,,) (,,) cytes(%) C seg. (%) (X lOt) (ng/ml) (pg/ml)
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TABLE I RESULTS OF THE EXAMINATIONS ON PATIENTS RECEIVING ANTICONVULSANTS (3)
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5502.241 132 6 D+M+P 5115.1 I 442 11.09140 I 91 I 5600 1 8.61 136
42 I 30 6 D + M + P 4 Ill.0 I 294 I I. 20 1 30 1 104 111600 I 7-
i
-55--'--2-.o-j8;-
43125 6 I D+P 2 i 14.81 476 10.991421 88 I 5800118.61 96 1.5 1 1425
44-j41 6 I D+P 8116.0 i 505 1 0 .99 1 441_ 88 I 4200 i 8.21 196 1.2-11750
----:--------;-------7---;---';---,---
45 II 29 6 I D+M+P 2 1 16 . 2 1 467 i 1.11 46 93.51 6200115.0 I 139 2.0 I 2200
46 1
1
41 6 i D+P 1116.51530 1,1.00 46 1 87 I 5800[10.81127 3.0 1 1125
:_7---cc-1_2_O_6--,-1_D_+_P 2---,1_1_4_.3-----,;-1_4_20_--,-1_1_.0_9_41 I 97. 51 5500 III .8 I liS I. 5 I 300
_~~_~__ ! D+! ~J16.0 I 452 I 1.10 441 97.51 5300 1 7.911~~-'_ 550
D: Diphenylhydantoin, M: Myso1ine (primidone), P: Fhenobarbital
cells with an ocular micrometer.
(2) Serum iron levels: These were determined in thirty-seven patients by the
bathophenanthrolin method.
~3) Mean diam!?ter of buccal cel/nuclei: In fourteen patients, oral mucosa were
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taken by scraping the inside of the cheek with a piece of absorbent cotton. The
samples were smeared evenly on microscope slides, air dried and stained with
May-Grunwald-Giemsa stain. The mean diameter of two hundred nuclei in each
cases was determined by measuring both the long and short axes with an ocular
micrometer.
(4) Serum folate levels: These were assayed in 48 patients. The standard
method of WATERS and MOLLIN (12) using Lactobacillus casei (L. casei) as the
test organism was employed. The Difco "Folic acid casei medium" was used for
the assay. Normal range in this laboratory is 3.5-20 ng/ml.
(5) Serum BIZ levels: Serum BIZ levels were determined in 48patients by the
method of the Japan Vitamin Society (13). Normal range is 150-900 pg/ml.
(6) The effect offolic acid supplements: The effect of folic acid on the peripheral
blood, the serum folic acid and BIZ levels, the mean diameter of the buccal cell
nuclei was studied after administration of 5 mg of folic acid to fourteen patients
for a month.
2. In vitro growth inhibition studies b)' anticonvulsants.
Solution of DPH was obtained by diluting the "Aleviatin Na" solution (Dai-
nippon Seiyaku Co. Ltd.) with water. The concentrations used were 10/lg/ml and
100/lg/mi. The saturated solution of Primidone (Mysoline; Dainippon Seiyaku
Co. Ltd.) in water (about 500/--tg/ml) was diluted to 10/lg/ml and 100ltg/mi. The
phenobarbital solution was made by diluting a solution of 10 % "Phenobal"
(Fujinaga Seiyaku Co. Ltd.) with water. Growth inhibition was tested using L.
casei and L. leichmannii by adding the anticonvulsants in various concentrations
to the culture medium. The test was performed in duplicate. In one series, sera
of known levels of folic acid (15 ng/ml) and BIZ (250 pg/ml) were assayed by add.
ing the anticonvulsants. In the other series, the standard solutions of folic acid
(0.1 ng/ml) and BIZ (4/lg/ml) were mixed with the solutions of anticonvulsants.
3. Expenmental studies
(1) Animals: Mixed bred male rats weighing 150-240 g were used.
(2) Radioactive materials: 3H-folic acid with specific activity of 1.5 /lCi/mM
was obtained from the Radiochemical Center, Amersham, England. Solution of
50/lg/ml of folic acid labelled with 5 /lCi/ml of 3H-folic acid was made by adding
appropriate amount of nonradioactive folic acid to the original 3H.folic acid
solution. It was stored at -20°C.
(3) Experimental procedures: From the day before absorption test, rats were
kept fasted. They were anesthetized with ether gas and abdominal incision was
made. A polyvinyl catheter was placed in the duodenum via the stomach through
a small incision. Then, ligatures were made at the pylorus and at a point
midway between the pylorus and cecum, which was about 30 cm distal to the
pylorus. Seventeen rats were given 3H-folic acid 40 /lg/kg animal through the
catheter and then divided into four groups. Group A consisted of five rats and
served as control. Group B consisted of five rats and they were administered 5 mg
of DPH dissolved in 0.2 ml of the solvent, which consisted of 40 v/w % of
propylene glycol and 10.5 v/w96 of ethanol. Group C consisted of four rats and
they were administered 20 mg of DPH dissolved in 0.8 ml of the solvent. Group
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D consisted of three rats and they were given 0.8 ml of the solvent and also
served as control. After administering these drugs through the catheter, the tube
was washed once with one ml of 0.9 % NaGI solution. Then the tube was pulled
out and the ligature at the pylorus was tightened. The incision of the stomach
and that of the abdomen were closed. The rats were killed two hours later. The
small intestine including its contents was removed from the upper point of the
ligature at the pylorus to the distal site of the second ligature at the mid-point of
the small intestine. The livers and kidneys were also removed.
(4) Counting technique: All of the small intestine removed and its content
were homogenized in a glass homogenizer with 10-40 ml of 0.1 M phosphate
buffer (pH 6.0) containing 150 mg% of ascorbic acid. The livers and kidneys
were also homogenized respectively. After autoclaving the homogenates for ten
minutes at 121 o G, 0.5 ml of the aliquots was dissolved in one ml of H yamine
hydroxide 10.X OM/500 ml of p-(diisobutylcresoxyethoxyethyl dimethyl benzoyl
ammonium hydroxide)). Then, 10 ml of the scintillator solution containing 500
mg of 2-5-diphenyloxazole (PPO) and 25 mg of 1.4-bis 2-(5-phenyloxazolyl)
benzene (POPOP) in 100 ml of equivalent toluene ethanol solution (14) was added.
The specimens were counted in a Shimazu liquid scintillation counter, LSG.ll.
Quenching was corrected by the external standard method. Halfml of the standard
3H-folic acid solution (5 ,uGi/ml) was counted in the same way for the standard.
Radioactivity of the administered 3H-folic acid in each rats were caluculated by
multiplying the standard radioactivity with administered dosis. The radio-
activity recovered from the intestinal wall and its content was subtracted from
the administered radioactivity in each rats. The percentage of the remainder to
the administered folic acid was expressed as the absorbed percentage of folic acid.
RESULTS
(I) Hematological examinations: The results of the hematological
studies and serum folate and B12 assays performed in forty.eight subjects
who were receiving 'anticonvulsants are presented in Table 1 and Fig. 1.
g/d' XIO' . . % jJ.'
16 .I:· :i.:I.: :.
.: . i : I i I;! ji i!i n:' .r' 1.2 120: .: I4
.. I : . 40 iiLIi12 ...
..: .. ... 1.1
· i : J 110.. : ..
30 qqi
. i . :
1.0 • i •• 100• iii: · ..
2 20 : ! I : :
0.9
· ! . :
90 · : I i I4 · . I •.
10 •
0.8
Hb RBC Ht CI MCV
Fig. 1 Blood picture of patients receiving anticonvulsants
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Slight degree of hyperchromic and macrocytic anemias were observed in
eight of forty eight patients, Mean corpuscular volume (MCV, normal
range 83-94 cu, p.) was over 100 cu, fl, in twelve of forty. eight (25 %) sub.
jects on anticonvulants, In 22 patients (46~-6), MCV was over 95 cu. fl.,
MCD was over 8 fl. in 9 of 25 patients (36 %), Macrocytosis, that is over
5 % of red cells are more than 9 p. in its diameter, was detected in 19 of
25 (76 %) subjects, All had normal values in reticulocytes, platelets and
white blood cells, The increased hypersegmented neutrophils, that is over
20 % of neutrophils are more than four lobes, was observed in 6 of 25
patients (24 %), The results of the hematological examinations after folic
acid therapy were shown in Table 1 and Fig. 6. Decrease in MCV was
significant (t = 5, 13, P < 0 .0n Also the percentages of macrocytes de.
creased (t= 2.60, P < 0,05) and hypersegmented neutrophils decreased in
their percentages (t = 6.24, p<O, 00n
(2) Serum iron levels: 5 of 37 patients examined had high levels and
low levels were observed in only 2 (Fig. 2).
I1l1g/m l
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.. 100 ·: : : :
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•• : • I
... : ...
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(Nor~:13~J-20)
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(Normal .150-900)
Serum Iron Level
(Normal 80-120)
Fig. 2 Serum folic acid, vitamin B12 and iron levels of patients
receiving anticonvulsants
(3) Mean diameter of the buccal cell nuclei: The results of the measure.
ment of diameters of the nuclei of the buccal cells are presented in Fig, 3,
The mean diameter of the long axes was 11 ,6 fl. and that of the short axes
was 9,2/1. in 14 patients examined, The effect of folic acid on the mean
diameter of the oral cell neclei was also examined (Fig. 3). Decrease in the
size of the long axes by the administration of folic 'acid was stastically
significant (t= 3,43, p<O, 01), The short axes decreased in its size signifi.
cantly (t=2,688, p<O,05).
(4) Serum folic acid levels: Low serum folic acid levels (under 3,4 ngj
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Fig. 3 Mean diameter of nucleus of oral epithelial cells in patients recelvmg
anticonvulsants before and after administering 5 mg of folic acid for a month
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ml) were observed in 36 of 48 (75 %) subjects receiving anticonvulsants
(Fig. 2). In Fig. 4, correlation between the serum folic acid levels and
MeV was presented. In Fig. 5, correlation between the serum folic acid
levels and the percentages of hypersegmented neutrophils is shown.
(5) Serum B12 levels: No patient was found to have low serum B)2
80
before after
MeV
%
20
before after
Macrocyte ( ~ 9,u)
%
30
20
.before after
Hypersegmented
Neutrophils
Fig. 6 Influence of folic acid administration on blood cells (Folic
acid 5mg/day for a month)
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Fig. 7 Influence of·anticonvulsants on microbioassay systems
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(Fig. 2). Six patients whose levels were high were administered drugs
containing BJ2.
(6) In vitro studies: No suppressive effect was observed for the growth
of 1. casei and L. leichmannii in vitro by adding various anticonvulsants in
the medium of the bioassay systems. (Fig. 7).
(7) Results of experimental study using rats: As was exhibited in Table
2, the mean percentage of the absorbed amount of folic acid in Group A
was 56. I ± 6.8 %. Only in the group C, significant decrease of the
absorption was observed (t= 2.98, p<O. 05). No significant difference was
demonstrated in group Band D in the present study. Hepatic and renal
uptake of the absorbed folic acid were not different from each other among
the four groups.
TABLE 2 FOLIC ACID ABSORPTION IN RATS
Amounts Hepatic Renal
absorbed (%) uptake (%) uptake (%)
54.5 9.6 4.8
Group A 43.6 15.3 5.2
Folic acid 40 ltg/kg 59.9 10.1 5.0
alone 62.6 21.7 6.1
59.7 7.3 9.1
Mean±SD 56.1 ±6.8 12.8±5.2 6.0±1.6
Group B 64.0 7.3 7.3
57.4 13.5 3.0Folic acid 40 ltg/kg
68.8 8.2 4.3
and
DPH 4-6.8 21.1 8.45 mg
65.7 21.8 11.9
Mean±SD 60.5±7.8 14.4±5.5 7.0±3.3
Group C 48.8 14.7 7.4
Folic acid 40 ltg/kg 40.9 12.1 7.9
and 38.3 8.9 4.0
DPH 20 mg 46.6 9.2 7.1
Mean±SD 43.6±4.3 11.2±2.4 6.6±1.5
Group D 57.0 12.3 7.9
Folic acid 4Oltg/kg 52.0 11.7 8.2
and
the solvent 59.9 12.2 7.6
Mean±SD 56.6±3.3 12.1±0.3 7.9±0.2
Significant difference exists only in the amounts absorbed in
Group A: Group C (t=2.98, p<0.05).
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It is now well established that megaloblastic anemia during anticonvul-
sant drug therapy is due to folic acid deficiency 0, 2, 3, 4, 5). Notwith.
standing the rare occurrence of megaloblastic anemia, subclinical folic
acid deficiency has been frequently observed in nonanemic patients receiv.
ing anticonvulsants (6, 7, 8, 9, 10). High incidence of macrocytosis in
nonanemic epileptic patients was first reported by HAWKINS and MEYNELL
in 1958 (5). They confirmed that macrocytosis was a sign of folic acid
deficiency by demonstrating -a decrease of macrocytosis after folic acid
administration. Though the incidence of macrocytosis was low (8-13 %)
in the investigations reported by MULPAS et al. (7), REYNOLDS et al. (8) and
CHILD et al. (0), correction of macrocytosis was made by folic acid admi.
nistration (0). A correlation existed between serum folic acid levels and
macrocytosis. Also a good correlation was demonstrated between sub.
normal serum folic acid levels and increase of hypersegmented neutrophils.
Macrocytosis was also present as judged by diameter of the buccal cells
before and after the administration of folic acid. Changes in epithelial
cells covering a variety of body surfaces were ob~erved in megaloblastic
anemias 06, 17) and in nonanemic B12 deficient patients (20). Effect of
the administration of folic acid on the macrocytosis (red blood cells and
buccal cell nuclei) and the increased percentage of hypersegmented
neutrophils were prominent in reversing these signs to normal. In the pre.
sent study, hematologic study and direct assay of serum folic acid levels
were performed. Anemia observed in 8 of 48 patients were very mild in
its degree. Macrocytosis was observed in 46 % and subnormal serum folic
acid levels in 75 % subjects investigated in the present study. The high
incidence of subnormal serum folic acid levels found in this investigation
is more in agreement with that found by REYNOLDS et al. (8) than with
KLIPSTEIN (6) (53%), MULPAS et al. (7) (37 %), CHILD et al. (0)(27 %) and
DAHLKE et al. (9) (54 %). Therefore the present study revealed that sub.
clinical folic acid deficiency is common among the patients receiving anti.
convulsants.
The mechanism of anticonvulsant.induced folic acid deficiency reo
mains unsettled at the present time. There are three main hypothese about
the mechanism. Attentions have been called to the structural resemblance
of the drugs to that of folic acid (19, 20). The inhibitory effect of anti.
convulsants to the growth of folic acid requiring microorganisms (Try.
panosoma crithidia fasciculata (21) and E. coli mutant (22)) was presented
as the evidence of this hypothesis. But HAMFELT et al. (23) could not
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observe any inhibitory effect of the drugs on dihydrofolic acid reductase,
methyltetrahydrofolate dehydrogenase of formyltetrahydrofolate synthe-
tase. No inhibitory effect of the anticonvulsants to the growth of L. casei
in vitro was observed by many workers (6, 9, 19, 24). The present study
also revealed that anticonvulsants did not inhibit the growth of L. casei
and L. teichmannii (Fig. 7). Therefore the 'competitive inhibition theory is
not supported (25).
The second hypothesis is presented by HOFFBRAND and NECHELES (26)
and ROSENBERG et at. (27). Most dietary folate are polyglutamates (28, 29).
Gamma-glutamyl-car boxypeptidase (conjugase, which splits glutamic acid
chain from folate polyglutamates at the small intestinal mucosa.) is reo
quired for the absorption of polyglutamates (30, 31, 32). Inhibitory effect
of DPH on this enzyme was suggested by HOFFBRAND et at. and ROSENBERG
et at. Although this hypothesis is attractive, recent studies (32, 33, 34)
could not confirm this.
The third hypothesis is that anticonvulsants interfere with the absorp-
tion of free folic acid from the small intestine. MEYNELL (35) observed
impaired absorption of 5 mg of folic acid when the anticonvulsants were
given immediately before folic acid but not when they were given two
hours after folic acid. DAHLKE et at. (9) demonstrated the malabsorption
of folic acid by performing folic acid tolerance test at 0, 4, 12, 16, and 20
hours after DPH administration in man and showing a progressive rise in
serum folic acid levels as DPH was withheld for longer periods prior to the
administration of 600 ,/I.g of folic acid,
HEPNER (36) studied absorption of folic acid from the small intestine
of rats and suggested that DPH inhibited absorption of folic acid, GERSON
et at. (37) also reported the inhibition of folic acid absorption in man.
Although the investigators who demonstrated conjugase inhibition by
DPH found normal absorption of free folic acid (26, 27), the hypothesis
that DPH interfere with the absorption of folic acid is most substantiated.
Absorption of folic acid occurs in the jejunum by an active process in
man (38). In rats, folic acid is also absorbed in the jejunum (36, 39, 40,
41). In the present study, absorption of folate in rats were examined only
at the jejunum. Absorbed amount of folic acid was revealed indirectly in
the presen t study by subtracting the recovered radioactivity of the small
intestine and its content from the administered one in each rats. Percen.
tages of the subtracted radioactivity to the administered one are presented
as the percentages of absorbed folate. Though the percentages would not
be completely accordant with that of absorbed folic acid, they may be
comparable among the four groups in this study as the technique used was
12
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the same, Significant difference in the percentages between the group C
(administered with 20 mg of DPH) and the control group (group A) is due
to difference in the absorption of folic acid, because DPH did not inter.
fere with folic acid utility in the present in vitro study using folic acid
requiring microorganism (L. casei). In the present experiment using rats,
DPH interfered with the absorption of folic acid only after the administ.
ration of large dose (20 mg), not after small dose (5 mg). This observation
does not conflict with that of HEPNER (36) who demonstrated slight inhibi·
tion of folic acid absorption by 5 mg of DPH with 1.5 ,/I.g of 3H.labelled
folic acid. The dose of folic acid administered in the present study was 40
,ag/kg, that was about 6 f1.g to 9.6 /lg as the weights of rats were 150-240 g.
HEPNER and HERBERT (42) indicated that DPH could inhibit the uptake
of folic acid by mucosal cells only when it was given in a w/w ratio of
la, 000 DPH: 1 folic acid. In this study, it was demonstrated that 5 mg
of DPH did not interfere with the absorption of folic acid (w/w ratio of
10,000 DPH: 12-19.2 folic acid) but that 20 mg of DPH impaired folic
acid absorption (w/w ratio of 10,000 DPH : 3-4.8 folic acid). The results
are in accordance with that of HEPNER and HERBERT. Recently BENN et at.
(43) investigated the effect of DPH and sodium bicarbonate on jejunal pH
and on the absorption of folic acid in man,
Suggestion was made that changes in the bulk phase of intraluminal
pH might have a profound effect on the absorption of folic acid in epilep.
tics and in normal subjects. Although the solvent of DPH used in the
present study had an alkaline pH, it did not inhibit the absorption of folic
acid. DPH was essential for the malabsorption of folic acid. Therefore it
is strongly suggested that interference of DPH on the absorption of folic
acid depends on quantity balance of the two substances in the jejunum.
This suggestion can explain well the fact that folic acid deficiency is so
rare among patients taking enough foods and rather frequent among
mentally defective patients taking inadequate diets.
As was suggested in the previous study of the author (4), the most
important factor for the manifestation of megaloblastic anemia due to
anticonvulsants is the amount of folic acid taken from diets.
CONCLUSION
A high incidence of subnormal serum folic acid levels was observed
in 48 patients receiving anticonvulsants (75 %). In peripheral blood,
macrocytosis was detected in 46 % and an increase of hypersegmented
neutrophils was also seen in 24 % of the patients. Correlation existed
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between these signs and low serum folate levels. The growth response of
Lactobacillus casei and L. leichmannii was not suppressed by the addition
of various anticonvulsants to the medium of the bioassay systems. Admi.
nistration of 5 mg of folic acid for a month corrected macrocytosis and an
increase of hypersegmented neutrophils significantly. Folic acid supply
also decreased mean diameters of the nuclei of oral epithelial cells signifi-
cantly. It is concluded that subclinical folic acid deficiency is common
among the patients receiving anticonvulsants.
Absorption of 3H.folic acid from the small intestine of rats was inhibi-
ted by large dose of diphenylhydantoin (20 mg) not by 5 mg. This fact
suggests that in patients on diphenylhydantoin, the quantity balance of
folic acid and diphenylhydantoin in the intestine regulates the absorption
of folic acid.
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